Zobrazeno 1 - 10
of 839
pro vyhledávání: '"McClune, B."'
Autor:
Wagner CB; Department of Pharmacy, University of Utah Hospitals and Clinics, Huntsman Cancer Institute, UT, USA., Julian K; Department of Pharmacy, University of Utah Hospitals and Clinics, Huntsman Cancer Institute, UT, USA., Bryan B; Department of Pharmacy, University of Utah Hospitals and Clinics, Huntsman Cancer Institute, UT, USA., Steinbach MN; Internal Medicine, University of Utah Health Huntsman Cancer Institute, UT, USA., Shewan S; Internal Medicine, University of Utah Health Huntsman Cancer Institute, UT, USA., Maxwell L; Internal Medicine, University of Utah Health Huntsman Cancer Institute, UT, USA., Vigil M; Internal Medicine, University of Utah Health Huntsman Cancer Institute, UT, USA., Mohyuddin GR; Internal Medicine, University of Utah Health Huntsman Cancer Institute, UT, USA., Godara A; Internal Medicine, University of Utah Health Huntsman Cancer Institute, UT, USA., McClune B; Internal Medicine, University of Utah Health Huntsman Cancer Institute, UT, USA., Galarza Fortuna G; Internal Medicine, University of Utah Health Huntsman Cancer Institute, UT, USA., Sborov D; Internal Medicine, University of Utah Health Huntsman Cancer Institute, UT, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep; Vol. 65 (9), pp. 1362-1365. Date of Electronic Publication: 2024 Jun 02.
Autor:
Steinbach M; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT. Electronic address: mary.steinbach@hsc.utah.edu., Neupane K; Department of Internal Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, New York, NY., Aziz M; Division of Gastroenterology and Hepatology, University of Toledo, Toledo, OH., Lee-Smith W; Mulford Health Science Library, University of Toledo, Toledo, OH., Julian K; Department of Pharmacy, Huntsman Cancer Hospital, Salt Lake City, UT., Godara A; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT., McClune B; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT., Kelkar AH; Dana Farber Cancer Institute, Boston, MA., Sborov D; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT., Mohyuddin GR; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Jan; Vol. 24 (1), pp. 15-22. Date of Electronic Publication: 2023 Aug 28.
Autor:
Bindal P; Division of Hematology and Hematological Malignancies, University of Massachusetts, Worcester, MA, USA., Najjar M; Department of Medicine, University of Balamand, Beirut, Lebanon., Koehn K; Mercy Health Center, Springfield, MO, USA., Godara A; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Sborov DW; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., McClune B; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Julian K; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Wagner C; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Mohyuddin GR; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Jul-Aug; Vol. 64 (7), pp. 1340-1343. Date of Electronic Publication: 2023 May 11.
Autor:
Leslie, L., Tees, M., Flinn, I. W., Rodriguez, T. E., Baird, J. H., Deol, A., Mead, M., Bachier, C., Rapoport, A. P., McClune, B., Hoda, D., Perales, M., Zheng, Y., Filosto, S., Davis, M., Miao, H., Kim, J. J., Oluwole, O. O.
Publikováno v:
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p843-845, 3p
Autor:
Etekal T; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Koehn K; Division of Hematological Malignancies and Cellular Therapeutics, University of Kansas, Lawrence, Kansas, USA., Sborov DW; Division of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, Utah, USA., McClune B; Division of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, Utah, USA., Prasad V; Division of Hematology/Oncology, University of California San Francisco, San Francisco, California, USA., Haslam A; Department of Epidemiology/Biostatistics, University of California San Francisco, San Francisco, California, USA., Berger K; Patient Advocate, University of Hartford, West Hartford, Connecticut, USA., Booth C; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada., Al Hadidi S; Myeloma Institute, The University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Abdallah AO; Division of Hematological Malignancies and Cellular Therapeutics, University of Kansas, Lawrence, Kansas, USA., Goodman A; Division of Blood and Marrow Transplantation, University of California San Diego, La Jolla, California, USA., Mohyuddin GR; Division of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, Utah, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2023 Mar; Vol. 200 (5), pp. 587-594. Date of Electronic Publication: 2022 Dec 10.
Autor:
Vardell VA; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA., Ermann DA; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA., Tantravahi SK; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA., Haaland B; Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA., McClune B; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA., Godara A; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA., Mohyuddin GR; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA., Sborov DW; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Jan; Vol. 98 (1), pp. 41-48. Date of Electronic Publication: 2022 Nov 07.
Autor:
McInturf G; School of Medicine, University of Kansas Medical Center, Lawrence, Kansas, USA., Younger K; School of Medicine, University of Kansas Medical Center, Lawrence, Kansas, USA., Sanchez C; School of Medicine, University of Kansas Medical Center, Lawrence, Kansas, USA., Walde C; School of Medicine, University of Kansas Medical Center, Lawrence, Kansas, USA., Abdallah AO; School of Medicine, University of Kansas Medical Center, Lawrence, Kansas, USA., Ahmed N; School of Medicine, University of Kansas Medical Center, Lawrence, Kansas, USA., Shune L; School of Medicine, University of Kansas Medical Center, Lawrence, Kansas, USA., Sborov DW; Division of Hematology, Huntsman Cancer Center, University of Utah, Salt Lake City, Utah, USA., Godara A; Division of Hematology, Huntsman Cancer Center, University of Utah, Salt Lake City, Utah, USA., McClune B; Division of Hematology, Huntsman Cancer Center, University of Utah, Salt Lake City, Utah, USA., Sinclair CT; School of Medicine, University of Kansas Medical Center, Lawrence, Kansas, USA., Mohyuddin GR; Division of Hematology, Huntsman Cancer Center, University of Utah, Salt Lake City, Utah, USA.
Publikováno v:
European journal of haematology [Eur J Haematol] 2022 Nov; Vol. 109 (5), pp. 559-565. Date of Electronic Publication: 2022 Aug 19.
Autor:
Mohyuddin GR; Division of Hematology, Huntsman Cancer Center, University of Utah, Salt Lake City, UT 84106, USA. Electronic address: g.mohyuddin@hci.utah.edu., Ahlstrom JM; HealthTree Foundation, MyelomaCrowd by HealthTree, HealthTree Foundation, Lehi, UT, USA., Chmielewski CA; HealthTree Foundation, MyelomaCrowd by HealthTree, HealthTree Foundation, Lehi, UT, USA., Sweeney NW; HealthTree Foundation, MyelomaCrowd by HealthTree, HealthTree Foundation, Lehi, UT, USA., Molina TH; HealthTree Foundation, MyelomaCrowd by HealthTree, HealthTree Foundation, Lehi, UT, USA., Cheung CS; HealthTree Foundation, MyelomaCrowd by HealthTree, HealthTree Foundation, Lehi, UT, USA., Ballard EW; HealthTree Foundation, MyelomaCrowd by HealthTree, HealthTree Foundation, Lehi, UT, USA., Seng FF; HealthTree Foundation, MyelomaCrowd by HealthTree, HealthTree Foundation, Lehi, UT, USA., Van Oekelen O; Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA., Godara A; Division of Hematology, Huntsman Cancer Center, University of Utah, Salt Lake City, UT 84106, USA., McClune B; Division of Hematology, Huntsman Cancer Center, University of Utah, Salt Lake City, UT 84106, USA., Sborov D; Division of Hematology, Huntsman Cancer Center, University of Utah, Salt Lake City, UT 84106, USA.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2022 Oct; Vol. 9 (10), pp. e716-e719.
Autor:
Steinbach M; Department of Internal Medicine, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA., Julian K; Department of Pharmacy, The University of Utah, Salt Lake City, UT, USA., McClune B; Department of Internal Medicine, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA., Sborov DW; Department of Internal Medicine, Huntsman Cancer Institute, The University of Utah, 2000 Circle of Hope Drive, Salt Lake City, UT 84112, USA.
Publikováno v:
Therapeutic advances in hematology [Ther Adv Hematol] 2022 Jul 15; Vol. 13, pp. 20406207221100659. Date of Electronic Publication: 2022 Jul 15 (Print Publication: 2022).
Autor:
Gil K; Department of Internal Medicine, University of Colorado School of Medicine, Aurora, USA., Abbasi S; Department of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Kansas City, USA., Mehta K; Department of Oncology, Kansas University Medical Center, Kansas City, USA., McClune B; Division of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, USA., Sborov D; Division of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, USA., Ahmed N; Department of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Kansas City, USA., Abdallah AO; Department of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Kansas City, USA., Ganguly S; Department of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Kansas City, USA., McGuirk J; Department of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Kansas City, USA., Shune L; Department of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, Kansas City, USA., Mohyuddin GR; Division of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, USA.
Publikováno v:
Clinical hematology international [Clin Hematol Int] 2022 May 11; Vol. 4 (1-2), pp. 56-59. Date of Electronic Publication: 2022 May 11 (Print Publication: 2022).